Table of content

Supplementary Materials and Methods 3
References 7 Figure S1 . p63 expression in p63 +/L514F mice 9 Figure Table S1 . Microarray analysis of p63 target genes 20 Table S2 . Microarray analysis of FGF signaling components encoding genes 21 Table S3 . Mutations in AEC patients used in this study 22 Table S4 . List of oligonucleotide primers 23
Supplementary Materials and Methods
Generation of the p63 +/L514F ES cells, ES and mouse screening
L514F mutation was inserted into the p63 locus in E14TG2a ES cells by recombineering (Liu et al, 2003) . A portion of the p63 gene from exon 12 to the 3'UTR was subcloned into a pBluescript vector (pBS) DNA from mouse BAC clone bMQ-241L2 via gap repair, essentially as previously described (Liu et al, 2003) . Miniarms were cloned into the NotI and SpeI sites of pBS using 
3'UTRRev oligonucleotide primers. The vector was subsequently linearized with
HindIII and electroporated into the recombinogenic bacterial strain EL350
containing the bMQ-241L2 BAC clone to obtain the repaired vector. The positive selection marker PGK-Neo and exon 13 containing the diagnostic EcoRI site and the TTA to TTT mutation (L514F) was inserted in one recombineering step.
Mutant exon 13 was amplified by PCR from a pCMV-FLAGmouse p63 L514F
with NotI-ex13For and EcoRI-ex13Rev primers. Intron 13 was PCR-amplified from the repaired vector with BamHI-intron13For and SalI-intron13Rev primers.
The PCR amplified regions were inserted by cloning in the pL251 vector containing the PGK-Neo cassette. The resulting minitargeting vector was digested with NotI -SalI and electroporated in EL350 E. Coli bacterial strain together with the repaired vector containing the p63 sequence. The final vector containing a PGK-neo cassette flanked by loxP sites and the L514F point mutation in exon 13 was electroporated into mouse E14Tg2A (129/Ola) ES cells.
Twenty-four hours after electroporation ES cells were selected with 100 µg/ml G418 (Invitrogen) for 7 days. Neo-resistant ES clones were screened at 3' and 5'
for the correct insertion in the p63 endogenous locus by PCR analysis using an oligonucleotide annealing in the neomycin cassette and an one annealing in the genomic DNA (5' insertion: EsScreen5'For and EsScreen5'Rev primers; 3' insertion: EsScreen3'For and EsScreen3'Rev primers). The homologous recombination event was confirmed by Southern blotting.
Genomic DNA was digested with EcoRI and analyzed with a probe located upstream of the recombinant targeted site. The wild-type allele resulted in a band of 5392 bp. The recombinant ES clone contained the wild-type band as well as a recombinant band of 3216 bp, due to insertion of a diagnostic EcoRI site at the 5' end of PGK-Neo cassette and thus consistent with the homologous recombination event. The presence of the mutation in the endogenous locus was confirmed by sequencing of ES genomic DNA. An ES positive clone was injected into C57BL/6 blastocysts, and six chimeras from a first injection and ten chimeras from a second injection were obtained. The chimeras were all tested for germline transmission by breeding with C57BL/6 females, and were subsequently bred with female mice from C57BL/6, or BALB/c, DBA/1, CBA, 129/Sv and C3H strains in an attempt to rescue the lethal phenotype. Offspring was genotyped for germline transmission of the p63 L514F wild-type and mutant allele by PCR using tail genomic DNA and specific primers (Screen-ex13L514F-For and Screenex13L514-wild-type-Rev or Screen-ex13L514F-Mut-Rev). p63 +/-mice were obtained from Jackson Laboratory (Mills et al, 1999) .
Skin Barrier Assay
To perform X-gal staining, unfixed embryos were washed in PBS and then incubated overnight at 37 °C in 5-bromo-4-chloro-3-indlyl-b-D-galactopyranoside (X-gal) reaction mix (100 mM NaPO4, 
Skeletal preparation
To analyze the whole skeleton newborn mice were dissected to remove skin, muscle, and fat and kept in acetone to remove further fat for 3 days. They then were stained with 0.09% alizarin red S and 0.05% Alcian blue in a solution containing ethanol, glacial acetic acid, and water (67:5:28) for 48 h at 37°C. After staining, mice were transferred to 1% potassium hydroxide until the skeleton was clearly visible. Mice were preserved in 100% glycerol with gradual increase in concentration.
Antibodies
The following primary antibodies were used for immunofluorescence and 
Human subjects
Heterozygous mutations have been described by Rinne and coworkers (Rinne et al, 2009 ) and are listed in Table 2 . Mutation C519R has been identified by CEINGE Sequencing Core for mutation analyses from a patient identified by G.T.
The Institutional Review Boards for Human Subject Research approved the research study. Written, informed consent was obtained from the parents of all children younger than 18 years and directly from all individuals 18 years of age or older.
Microarray analysis
We measured global changes in gene expression by microarray analysis on freshly isolated E14.5 skin from wild-type and p63 +/L514F embryos, E18.5 epidermis, and primary keratinocytes cultured under growing conditions for one week. Three (E18.5 epidermis) or two (E14.5 skin, keratinocytes) independent mutant RNA and corresponding wild-type samples were analyzed by Affymetrix mouse 430A array at Coriell Institute (Camden, NJ, USA). The data generated underwent quality control and analysis using as previously described (Della Gatta et al, 2008) . The entire dataset of microarray data will be published elsewhere (Ferone et al., manuscript in preparation).
Whole mount in situ hybridization.
Paraformaldehyde-fixed embryos at E14.5 were processed as described and +/+ cells at the third passage under clonogenic conditions reveals that mutant p63 is not lost in long term cultures (n=8 Table S4 . List of oligonucleotide primers used in this study. 
Oligonucleotide primers for miniarms generation by
